Correlation Between Unity Biotechnology and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Unity Biotechnology and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Anebulo Pharmaceuticals.
Diversification Opportunities for Unity Biotechnology and Anebulo Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Unity and Anebulo is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Anebulo Pharmaceuticals
Considering the 90-day investment horizon Unity Biotechnology is expected to generate 1.1 times more return on investment than Anebulo Pharmaceuticals. However, Unity Biotechnology is 1.1 times more volatile than Anebulo Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 144.00 in Unity Biotechnology on October 24, 2024 and sell it today you would earn a total of 35.00 from holding Unity Biotechnology or generate 24.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Unity Biotechnology |
| Anebulo Pharmaceuticals |
Unity Biotechnology and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Anebulo Pharmaceuticals
The main advantage of trading using opposite Unity Biotechnology and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |